Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine for carpal tunnel syndrome
IRCT20190428043404N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in carpal tunnel syndrome (CTS) comparing Clemastine + splint with Placebo + splint (2 arms). Primary endpoints: VAS pain score, Median SNAP amplitude and 3 more. Started May 2023; status: completed.
02
Drugs
clemastine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20190428043404N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190428043404N2.